Agilent: Back To The Lab - [Business Breakdowns, EP.223]

| Podcasts | August 17, 2025 | 159 views | 41:32

TL;DR

Agilent Technologies, spun from HP in 1999, operates a razor-and-blades model selling analytical lab instruments with two-thirds of revenue coming from recurring consumables and services, fortified by regulatory switching costs and dominance in gas chromatography across diversified end markets.

💰 Razor-Blade Economics & Recurring Revenue 3 insights

Recurring revenue dominates the business model

Approximately two-thirds of Agilent's revenue comes from consumables and services rather than initial instrument sales, with customers spending roughly $100,000 over a machine's lifetime on replacement columns and maintenance after the initial $100,000 purchase.

Regulatory specifications create sticky revenue

FDA drug approvals often explicitly mandate specific Agilent instruments and consumables in quality control protocols, making it prohibitively expensive and risky for pharmaceutical customers to switch vendors post-approval.

Service attach rates steadily expanding

The percentage of installed instruments under active service contracts has grown from the high-20s to low-30s percent range, increasing approximately 1% annually as Agilent leverages its unique ability to service third-party equipment alongside its own.

🎯 Strategic Market Position 3 insights

Dominant share in gas chromatography

Agilent controls approximately two-thirds of the global gas chromatography market, a specialized niche used for testing gases in environmental monitoring, battery production, and semiconductor manufacturing where samples can be heated.

Diversified exposure reduces concentration risk

Unlike competitor Waters which derives 60% of sales from pharma, Agilent's revenue is split across pharmaceutical (33%), chemicals/advanced materials (20%), food/environmental testing (20%), and academia (10%), providing stability through economic cycles.

Focused specialization versus broad competition

While Thermo Fisher offers general lab supplies ranging from refrigerators to test tubes across a $43 billion revenue base, Agilent concentrates on high-value analytical instruments where it maintains number one or two market share positions.

🏭 Corporate Evolution from HP 2 insights

Strategic divestitures created pure-play focus

After spinning from HP in 1999, Agilent sold its medical device business to Philips in 2001 and spun off its cyclical electronic measurement division as Keysight Technologies in 2014, transforming into a focused life sciences analytical tools company.

Silicon Valley engineering culture endures

Headquartered near the original HP garage in Santa Clara, Agilent maintains the HP Way ethos with long-tenured engineer-managers and demonstrated employee loyalty through policies like no layoffs during the COVID-19 pandemic.

Bottom Line

Agilent offers exposure to a high-moat, non-cyclical business where regulatory requirements and mission-critical consumables generate predictable recurring revenue streams, making it a defensive compounder with significant runway in the $160 billion lab instrumentation market.

More from Invest Like the Best

View all
Cloudflare: Leading Cybersecurity [Business Breakdownes Ep 241]Cloudflare Final
1:09:47
Invest Like the Best Invest Like the Best

Cloudflare: Leading Cybersecurity [Business Breakdownes Ep 241]Cloudflare Final

Cloudflare processes over 20% of global web traffic by operating as a unified reverse proxy that combines security, speed, and content delivery into a single network. The company differentiated itself from legacy vendors through a product-led growth strategy targeting the long tail of websites, while leveraging commodity hardware and strategic ISP peering relationships to build a highly defensible, scalable infrastructure.

about 1 month ago · 8 points
How Investors Are Using AI [Business Breakdowns: Episode 240]
48:34
Invest Like the Best Invest Like the Best

How Investors Are Using AI [Business Breakdowns: Episode 240]

David Plawn explains how investors are leveraging AI to solve fundamental research bottlenecks—specifically information overload, idea generation, and position monitoring—while emphasizing that effective AI use requires treating prompts like delegating to a smart but context-lacking analyst and calibrating accuracy requirements based on the research stage.

about 2 months ago · 9 points
GE Aerospace: Full Throttle [Business Breakdowns Episode 235]
58:51
Invest Like the Best Invest Like the Best

GE Aerospace: Full Throttle [Business Breakdowns Episode 235]

GE Aerospace has emerged as a pure-play aerospace powerhouse with dominant market positions in commercial jet engines, generating predictable cash flows from a $175 billion backlog while benefiting from Larry Culp's operational turnaround that shed the conglomerate structure to focus on this high-margin crown jewel.

about 2 months ago · 9 points
Databricks: From Data to Decisions [Business Breakdowns Episode 238]
1:14:17
Invest Like the Best Invest Like the Best

Databricks: From Data to Decisions [Business Breakdowns Episode 238]

Databricks evolved from a Berkeley open-source project (Apache Spark) into a multi-billion dollar data platform by solving the enterprise data preparation bottleneck, successfully monetizing through proprietary performance improvements while expanding from serving data engineers to SQL analysts to compete directly with data warehouses.

about 2 months ago · 7 points